Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five ...

SAN DIEGO -- A fixed-duration oral combination significantly reduced the risk of disease progression or death compared with ...

-Company expects to provide a broader update across oncology and autoimmune indications in mid-2025- ...

Patients treated with Polivy in combination with R-CHP required fewer subsequent treatments, potentially reducing burdens on patients and healthcare systems1 These encouraging five-year results ...

Studies include the Phase III SUNMO trial evaluating the efficacy and safety of subcutaneously administered Lunsumio ® (mosunetuzumab-axgb) in combination with intravenous (IV) Polivy versus IV ...

A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...

Washington: During ACR Convergence 2024, the American College of Rheumatology (ACR) unveiled a summary of the 2024 Guideline ...

intravenous for very severe or life-threatening disease Cyclophosphamide in severe disease; intravenous globulin, plasma exchange, rituximab in life-threatening situations but based on limited ...

Credit: Getty Images The American College of Rheumatology has released a new guideline summary for the screening, treatment, and management of lupus nephritis. The guideline authors recommend ...

a boxed warning was removed from treatment with the Sandoz injection and is now instead incorporated into the Warnings and Precautions section of the label. The new and revised label indications also ...

Nov 19 (Reuters) - Merck (MRK.N), opens new tab said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of ...

The Supreme Court questioned the Delhi government on Monday (November 18) over the “delay” in implementing stage IV of the Graded Response Action Plan (GRAP). With smog and high levels of air ...